Abstract
This report analyzes the worldwide markets for Prescription Drugs in US$
Billion by the following therapeutic class -Oncologics/ Cancer Drugs, Lipid
Regulators, Respiratory Agents, Proton Pump Inhibitors, Antidiabetics,
Antipsychotics, Antidepressants, Angiotensin II Antagonists, Anti-Epileptics,
Autoimmune Agents, and Others. The report provides separate comprehensive
analytics for the US Canada, Japan, Europe, Asia-Pacific, Latin America, and
Rest of World. Annual forecasts are provided for each region for the period
2006 through 2015. A five-year historic analysis is also provided for these
markets. The report profiles 292 companies including many key and niche
players worldwide such as Abbott Laboratories, Allergan, Inc., Amgen, Inc.,
AstraZeneca, Bayer AG, Bristol-Myers Squibb, Boehringer Ingelheim Group, Dr.
Reddy' s Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd.,
Genentech, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Inc., Merck & Co.
Inc., Merck Serono International S.A., Mylan, Inc., Novartis AG, Pfizer, Inc.,
Ranbaxy Laboratories Limited, Sanofi-Aventis SA, Sanofi Pasteur, Takeda
Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Watson
Pharmaceuticals, Inc., and Wyeth. Market data and analytics are derived from
primary and secondary research. Company profiles are mostly extracted from URL
research and reported select online sources.
| 
View Cart
